Standex International Corporation Form 4 Filings

Standex International Corp (SXI) reports that its VP & Chief Accounting Officer, Danielle Rangel, acquired 6 shares of common stock on September 30, 2026, pursuant to the Company’s Employee Stock Purchase Plan. The reported price was $232.1010 per share, and her direct holdings following the transaction were 339 shares.

Standex International Corp. VP and Chief Information Officer Max Arets acquired 11 shares of common stock on September 30, 2026, through the company’s Employee Stock Purchase Plan. The reported price was $232.1010 per share. After the acquisition, his direct holdings were 1,651.66 shares.

STANDEX INTERNATIONAL CORP (SXI) officer Max Arets, Vice President and Chief Information Officer, reported buying a total of 45 shares of Standex common stock on September 4, 2026 in two open-market transactions at per-share prices of $274.195 and $273.94. No Rule 10b5-1 trading plan is reported for these purchases.

STANDEX INTERNATIONAL CORP (SXI) director Thomas E. Chorman reported selling 50 shares of common stock on September 1, 2026 in an open-market or private transaction at $284.89 per share, for about $14,244.

The sale was made pursuant to an existing Rule 10b5-1 trading plan dated November 6, 2025, and Chorman now holds 12,316 shares directly.

Standex International Corp (SXI) reported that President, CEO and Chairman David A. Dunbar disclosed two indirect sales of SXI common stock on August 31, 2026. Acting as Trustee of a Trust, he sold 4,000 shares at a weighted average price of $290.8124 and 9,000 shares at a weighted average price of $290.8175, totaling 13,000 shares. These sales were made pursuant to an existing Rule 10b5-1 trading plan dated May 21, 2026. A separate line shows a direct holding of 11,305.9759 SXI shares after the reported date.

STANDEX INTERNATIONAL CORP (SXI) reported that Vice President Alan J. Glass sold 1,391 shares of common stock on 2026-08-24 in an open-market transaction. The weighted average sale price was $303.185 per share, with individual trades ranging from $302.21 to $304.42. After this sale, Glass directly held 22,722.945 shares of SXI common stock.

STANDEX INTERNATIONAL CORP (SXI) reported that Vice President, CFO and Treasurer Ademir Sarcevic sold 2,300 shares of common stock on 2026-08-24 in an open-market or private transaction. The weighted average sale price was $306.126 per share, with individual trade prices ranging from $300.49 to $308.885. Following this sale, Sarcevic directly holds 7,486 shares of SXI common stock.

STANDEX INTERNATIONAL CORP (SXI) reported equity-compensation activity for Alan J. Glass, its CLO, VP & Secretary. On August 21, 2026, various Phantom Stock Units and Restricted Stock Units vested under the Management Stock Purchase Plan and the 2018 Omnibus Incentive Plan and were converted into Common Stock, with some Phantom Stock Units returned to the company to reflect 68% performance achievement. Common shares were withheld at $310.28 per share to pay taxes on vesting of previously issued equity awards. On August 23, 2026, Glass also acquired 524 Phantom Stock Units in a contingent purchase that will vest three years after the purchase date in the form of Common Stock.

Standex International Corp (SXI) reported equity awards to officer Richard Colby Slaughter, its CLO, VP and Secretary. On 2026-08-23 he received 1,049 Restricted Stock Units that vest one-third each year on the award’s anniversaries, leaving him with 1,049 RSUs reported as outstanding.

He also received 1,049 Performance/Phantom Stock Units that cliff vest after a three-year performance period, with the payout ranging from 0% to 250% of the award based on company performance metrics, for 1,049 such units reported as held. In addition, he was granted a premium priced stock option for 5,734 shares of common stock, with an exercise price set at 10% above the closing market price on the grant date, vesting 25% per year over four years and expiring ten years from grant, with 5,734 options reported as held.

STANDEX INTERNATIONAL CORP (SXI) reported that officer Danielle Rangel, VP & Chief Accounting Officer, had multiple equity-compensation transactions. On 2026-08-23 she received grants of 146 Restricted Stock Units and 146 Performance/Phantom Stock Units under the 2018 Omnibus Incentive Plan, with the performance award eligible to range from 0% to 250% of target over a three-year period.

On 2026-08-21, previously granted Phantom Stock Units and Restricted Stock Units vested, including 193 shares of common stock delivered upon derivative exercises. Based on a 68% achievement factor, 40 Phantom Stock Units were disposed to align the award with actual performance, and 68 shares of common stock at $310.28 per share were sold to pay taxes on the vesting. The transactions reflect compensation vesting and tax withholding rather than open-market buying or selling.

Standex International Corp (SXI) reported multiple equity-related transactions by VP and Chief Information Officer Max Arets. On August 23, 2026 he received 382 Restricted Stock Units, 382 Performance Share Units as Phantom Stock Units that cliff vest after a three‑year performance period, an additional 172 Phantom Stock Units vesting after three years, and a premium priced stock option for 2,090 shares at $341.31 per share that vests over four years. On August 21, 2026 previously granted Restricted Stock Units totaling 176 and 168 units vested and converted into the same number of Common shares, with 41 and 43 shares withheld at $310.28 per share to pay taxes. That day he also acquired small fractional Common share amounts (1.402 and 0.07 shares) through the company’s Dividend Reinvestment Plan.

STANDEX INTERNATIONAL CORP (SXI) reported multiple equity-compensation transactions by President/CEO/Chairman David A. Dunbar. On August 23, 2026 he received grants under the 2018 Omnibus Incentive Plan, including 2,285 Phantom Stock Units tied to the Management Stock Purchase Plan, 7,156 Performance Share Units, 4,770 Restricted Stock Units, and a premium priced stock option for 32,600 shares at an exercise price of $341.31 per share.

On August 21, 2026 Phantom Stock Units and Restricted Stock Units vested, resulting in the conversion of 16,025 derivative units into Common Stock and a disposition of certain Phantom Stock Units to reflect a 68% performance achievement level. On the same date, an aggregate of 6,149 shares of Common Stock were delivered or withheld at $310.28 per share to pay taxes on vesting. Following these events, Dunbar also reported 88,973 shares of Common Stock held indirectly as Trustee of a trust.

STANDEX INTERNATIONAL CORP (SXI) reported multiple equity compensation and vesting events for Vice President/CFO/Treasurer Ademir Sarcevic. On 2026-08-23 he received awards of 1,933 Performance Share Units, 1,933 Restricted Stock Units, and 10,571 stock options with a $341.31 premium exercise price, all tied to the company’s 2018 Omnibus Incentive Plan. On 2026-08-21 various Phantom Stock Units and RSUs vested and were converted into a total of 4,077 shares of Common Stock, while 798 Phantom Stock Units were disposed of to true-up actual performance of 68% versus a 0–250% range. To cover tax liabilities on these vestings, 1,919 shares of Common Stock were delivered or withheld at $310.28 per share.

STANDEX INTERNATIONAL CORP (SXI) reported several equity-compensation transactions for Chief Strategy Officer Vineet Kshirsagar. On 2026-08-23 he received awards of 220 Phantom Stock Units under a management stock purchase plan, 401 performance-based Phantom Stock Units, 401 Restricted Stock Units, and a stock option for 2,195 shares with a $341.31 exercise price, all tied to the 2018 Omnibus Incentive Plan. On 2026-08-21 prior Phantom Stock Units and RSUs vested, delivering 239, 145, and 161 shares of common stock, while 113 Phantom Stock Units were forfeited to reflect 68% performance achievement. A total of 189 shares of common stock at $310.28 per share were withheld and disposed of to cover tax liabilities on these vestings.

STANDEX INTERNATIONAL CORP (SXI) reported equity compensation and related transactions for Chief HR Officer & VP Michelle Newbury. On 2026-08-23 she received awards under the company’s 2018 Omnibus Incentive Plan: 360 Performance Share Units (titled Phantom Stock Units) that cliff vest after a three-year performance period with the ultimate number of shares ranging from 0% to 250% of the award based on company performance metrics, 360 Restricted Stock Units vesting one-third per year on each anniversary of the grant, and a premium priced stock option for 1,969 shares of common stock with an exercise price of $341.31 per share that vests 25% per year over four years. On 2026-08-21, 126 Restricted Stock Units vested and were settled into 126 shares of common stock, and 36 shares of common stock were withheld and disposed of at $310.28 per share to pay taxes on the vesting of previously issued restricted stock and/or performance share units.

STANDEX INTERNATIONAL CORP (SXI) reported that director Charles H. Cannon Jr. acquired 286 Phantom Stock Units as a grant classified as a “grant, award, or other acquisition.” These units are tied to 286 shares of Common Stock and are scheduled to vest three years after the purchase date under the company’s Management Stock Purchase Plan component of the 2018 Omnibus Incentive Plan. Following this award, Cannon’s directly held Phantom Stock Units position reported in this filing is 286 units.

STANDEX INTERNATIONAL CORP (SXI) reported that director Barbara Joanne Edwards acquired 143 Phantom Stock Units on August 23, 2026. These units were granted under the Management Stock Purchase Plan component of the 2018 Omnibus Incentive Plan and are scheduled to vest three years after the purchase, in the form of Common Stock.

STANDEX INTERNATIONAL CORP (SXI) reported that director Robin J. Davenport acquired additional common stock on August 21, 2026. The filing shows an award-type acquisition of 2.681 shares at $308.075 per share, increasing Davenport’s direct holdings to 4,710.946 SXI shares. A footnote states the shares were obtained through the company’s Dividend Reinvestment Plan, indicating automatic reinvestment of dividends rather than an open-market purchase.

Slaughter Richard Colby reported acquisition or exercise transactions in this Form 4 filing.

Standex International Corp. (SXI) reported that officer Richard Colby Slaughter, CLO, VP and Secretary, received a grant of 2,285 Restricted Stock Units on August 10, 2026. These RSUs are tied to common stock and vest in three equal installments on August 10, 2027, August 10, 2028, and August 10, 2029. Following this award, he holds 2,285 RSUs directly.

Standex International director Thomas E. Chorman sold 50 shares of Common Stock on August 3, 2026 at $305.56 per share in an open-market or private transaction. Following the sale, he directly holds 12,366 shares. The trade was executed under a Rule 10b5-1 trading plan dated November 6, 2025.

Sarcevic Ademir reported acquisition or exercise transactions in this Form 4 filing.

Standex International Vice President, CFO and Treasurer Ademir Sarcevic received a grant of 2,152 Restricted Stock Units tied to the company’s common stock. The award was made under the company’s 2018 Omnibus Incentive Plan as compensation, not a market purchase. These RSUs vest one-third on July 1, 2028 and the remaining two-thirds on July 1, 2029. Following this grant, Sarcevic holds 2,152 RSUs directly.

Standex International director Thomas E. Chorman reported a small open-market sale of 50 shares of Common Stock. The shares were sold at an average price of $355.51 per share. After this transaction, he directly holds 12,416 shares. The sale was executed under an existing Rule 10b5-1 trading plan dated November 6, 2025, indicating it was pre-arranged rather than a discretionary trade.

Standex International director Barbara Joanne Edwards reported an amended insider filing showing an open-market sale of 150 shares of common stock at $311.045 per share. The sale was executed by a Donor Advised Fund for which she is an advisor and reflects indirect ownership.

Following the transaction, the filing reports that Edwards holds 5,519 shares of Standex common stock directly, while the Donor Advised Fund no longer holds shares reported as indirectly owned.

Director Barbara Joanne Edwards reported gifting a total of 300 shares of Standex International (Common Stock) on June 15, 2026. The transactions were coded as bona fide gifts, not market sales and carried a price of $0.00 per share.

Of the total, 150 shares were transferred from an indirect holding as an advisor of a charitable donor advised fund, and 150 shares were gifted from her direct holdings. After these gifts, she directly owns 5,519 shares of Standex International common stock.

Standex International director Thomas E. Chorman sold 50 shares of Common Stock in an open-market transaction. The shares were sold at a price of $272.82 per share.

After this sale, Chorman directly holds 12,466 shares. The transaction was executed under an existing Rule 10b5-1 trading plan dated November 6, 2025, indicating it was pre-scheduled.

Standex International director Barbara Joanne Edwards reported an open-market sale of 558 shares of Common Stock on May 27, 2026 at $274.81 per share. After this transaction, she directly holds 5,669 shares, indicating a relatively small, routine-sized disposition.

Rangel Danielle reported acquisition or exercise transactions in this Form 4 filing.

Standex International reported that VP & Chief Accounting Officer Danielle Rangel received a grant of 603 Restricted Stock Units tied to common stock. The award was granted at no cost and will vest in three equal installments on May 15, 2027, May 15, 2028, and May 15, 2029.

Standex International director Thomas E. Chorman reported a small open-market sale of company stock. On this Form 4, he sold 50 shares of Standex International common stock at an average price of $268.43 per share on May 1, 2026, and held 12,516 shares afterward. The filing notes that this sale was made under an existing Rule 10b5-1 trading plan dated November 6, 2025, indicating the transaction was pre-planned rather than timed discretionarily.

Standex International Corp executive Max Arets reported a routine tax-related share disposition. On April 8, 2026, 132 shares of common stock were forfeited at $272.83 per share to cover tax liability tied to vesting of previously issued restricted stock. After this withholding, Arets directly holds about 1,319.632 shares of Standex common stock.

Standex International chief legal officer Alan J. Glass reported a routine tax-withholding transaction related to vested restricted stock. On the event date, 204 common shares were forfeited at an implied price of $257.70 per share to cover tax liabilities. After this non-market disposition, he directly holds 22,722.945 common shares.

Standex International Vice President, CFO and Treasurer Ademir Sarcevic reported a tax-related share disposition. On April 1, 2026, 1,713 shares of common stock were forfeited at $260.09 per share to cover taxes on vesting of previously issued restricted stock. After this withholding, he directly holds 7,628 shares of Standex common stock.

Standex International director Thomas E. Chorman reported an open-market sale of 50 shares of Common Stock at $257.94 per share on April 1, 2026. The transaction was executed pursuant to an existing Rule 10b5-1 trading plan dated November 6, 2025.

After this sale, Chorman directly holds 12,566 shares of Standex International common stock, indicating the transaction represents a small portion of his reported holdings and appears to be a routine, pre-planned sale.

Standex International director Thomas E. Chorman reported an open-market sale of 50 shares of Standex International common stock at $259 per share on March 2, 2026. The sale was made under an existing Rule 10b5-1 trading plan dated November 6, 2025, and he now holds 12,616 shares directly.

Standex International director Thomas E. Chorman reported an open-market sale of 513 shares of common stock at $260 per share on February 27, 2026. After this transaction, he directly owns 12,666 shares of Standex International common stock.

Standex International director Barbara Joanne Edwards reported a charitable-type move involving company stock. On February 23, 2026, she transferred 58 shares of Standex International common stock as a bona fide gift with no consideration received. After this gift transfer, she directly owned 6,227 common shares of Standex International.

Standex International director Charles H. Cannon Jr. reported an open-market sale of 2,000 shares of common stock at $256.64 per share. The shares were held indirectly as Trustee of a Trust, which reported 13,046 shares remaining after the sale. Separately, Cannon reported 2,280 shares of common stock held directly, with this line reflecting a reported holding rather than a new transaction.

STANDEX INTERNATIONAL CORP/DE/ Chief Strategy Officer Kshirsagar Vineet sold 400 shares of common stock in an open-market transaction. The sale occurred on February 18, 2026, at a price of $260.10 per share. After this transaction, he directly owns 4,647 shares.

Standex International’s President, CEO, and Chairman David A. Dunbar reported indirect open-market sales of company common stock under a pre-arranged Rule 10b5-1 trading plan dated November 12, 2025. On February 17, 2026, a trust for which he serves as trustee sold 10,000 shares at a weighted average price of $255.98 per share and 5,000 shares at a weighted average price of $255.87 per share. Following these planned sales, indirect holdings held as trustee totaled 88,973 shares, and direct ownership stood at 1,429.9759 shares.

Standex International Corporation director Thomas E. Chorman reported a small planned sale of company stock. On February 4, 2026, he sold 50 shares of common stock at a price of $249.86 per share under an existing Rule 10b5-1 trading plan dated November 6, 2025.

After this transaction, Chorman beneficially owned 13,179 shares of Standex common stock, held directly in his name.

Standex International Corporation director Andy L. Nemeth reported buying additional company stock. On February 4, 2026, he purchased 2,000 shares of Standex common stock at a price of $245 per share. After this open-market purchase, he directly owns 8,639 shares of Standex common stock.

Standex International Corporation director reports share transfer to family trust. On 12/26/2025, a director of Standex International Corporation moved 1,295 shares of common stock from direct ownership to indirect ownership as trustee of the Cannon Family Trust, using transaction code G, which indicates a gift or similar transfer. After the transaction, the director held 2,280 shares directly and 15,046 shares indirectly as trustee, reflecting a change in how the shares are held rather than a purchase or sale in the open market.

Standex International Corporation (SXI) reported an insider transaction by a company director. On 11/20/2025, the director sold 1,000 shares of Standex common stock in an open-market transaction coded "S" at a price of $223.31 per share. After this sale, the director beneficially owns 13,229 shares of Standex common stock, held directly.

Standex International Corporation director reports stock purchase

A director of Standex International Corporation reported buying 1,500 shares of common stock on 08/29/2025 at a price of $205 per share. After this transaction, the director beneficially owns 6,000 shares of Standex common stock in direct ownership.

This report is an amendment that clarifies the transaction code, explaining that the original report inadvertently used a different code and that the transaction should be classified as a purchase.

Standex International Corporation (SXI) director transaction: A company director reported buying 2,000 shares of Standex common stock on 08/25/2025 at a price of $209.4959 per share. After this purchase, the director directly owns 4,500 shares of Standex common stock. This filing is an amended Form 4 that corrects the original report, which had mistakenly used transaction code "A"; the transaction is now shown as code "P", indicating an open market or private purchase.

Standex International (SXI) reported insider equity awards for its Chief HR Officer & VP on 11/10/2025. The filing shows an acquisition of 630 shares of common stock from a restricted stock grant, with 630 shares beneficially owned directly after the transaction.

The officer also received 378 Performance Share Units that cliff vest after a three‑year period, with the ultimate payout ranging from 0% to 250% of the award based on company performance metrics. In addition, 378 Restricted Stock Units were granted, scheduled to vest one‑third on August 23, 2026, one‑third on August 23, 2027, and one‑third on August 23, 2028.

Standex International (SXI) reported an insider transaction by its Chief Strategy Officer. On November 5, 2025, the reporting person sold 650 shares of common stock at a weighted average price of $233.37.

After the transaction, the insider beneficially owns 5,047 shares, held directly. The filing notes the sale occurred in multiple trades within a price range of $232.91 to $233.865, and detailed trade breakdowns are available upon request.

Standex International (SXI) executive reported an insider sale. The Vice President/CFO/Treasurer sold 1,823 shares of common stock on 11/04/2025, coded S (sale) on Form 4. The transaction was reported at a weighted average price of $230.12, with individual trades executed between $229.66 and $230.23.

Following the sale, the reporting person directly beneficially owns 9,341 shares. The filing notes the seller will provide full pricing breakdowns upon request.

Standex International (SXI) reported an insider transaction by its VP, Chief HR Officer. A Form 4 shows 111 shares of common stock were forfeited at $244.87 on 10/24/2025 to cover taxes tied to the vesting of previously issued restricted stock. Following the transaction, the officer directly owned 7,311 shares.

Standex International Corporation (SXI) reported a routine insider equity grant. A director acquired 639 shares of Common Stock on 10/21/2025 at a stated price of $0, reflecting a restricted stock award under the company’s 2018 Omnibus Incentive Plan.

The award vests three years after the date of grant. Following this transaction, the reporting person’s beneficial ownership stands at 14,229 shares, held directly.